DEF 14A: Real Good Food Company Seeks Stockholder Approval for Reverse Stock Split and Key Equity Transactions
Proxy Statement
The Real Good Food Company is asking stockholders to approve a reverse stock split and several equity transactions to regain compliance with Nasdaq listing requirements and secure crucial financing.
Summary
- The Real Good Food Company is holding a special meeting for stockholders to vote on several proposals.
- These proposals include a reverse stock split with a ratio between 5:1 and 30:1, to be determined by the Board of Directors.
- The company also seeks approval to issue additional Class B Common Stock related to an Exchange Agreement with Emblem Investments Fund I, LP and PMC Financial Services Group, LLC.
- Stockholders will also vote on the issuance of Class B Common Stock and Class C units exchangeable into Class A Common Stock, potentially up to 49.99% of the company's fully diluted equity.
- Another proposal involves issuing Class A Common Stock up to 25% of the fully diluted equity upon the exercise of existing warrants held by PMC.
- Finally, the company is seeking authorization to adjourn the special meeting if there are insufficient votes to approve the other proposals.
- These actions are aimed at maintaining the company's Nasdaq listing and addressing financial reporting deficiencies.
Sentiment
Score: 3
Explanation: The document highlights significant financial challenges and potential risks, including delisting and loan acceleration. While the company is taking steps to address these issues, the overall tone is concerning from an investment perspective.
Positives
- The proposed actions are intended to help the company regain compliance with Nasdaq listing requirements.
- The transactions with Emblem and PMC provide significant liquidity to the company.
- The company intends to use the proceeds from these transactions to become current with SEC reporting.
- The reverse stock split could increase the share price, potentially helping the company meet the minimum bid price requirement.
Negatives
- The reverse stock split may not increase the stock price and could decrease liquidity.
- The issuance of new shares will dilute existing stockholders' ownership.
- Emblem could gain significant control of the company through the proposed equity issuances.
- Failure to approve the proposals could lead to loan acceleration and potential delisting from Nasdaq.
- The company is currently not in compliance with various Nasdaq listing standards.
Risks
- The company faces the risk of delisting from Nasdaq if it fails to regain compliance with listing standards.
- The reverse stock split may not be effective in increasing the stock price.
- The company's loans with Emblem and PMC could mature on March 20, 2025, if certain proposals are not approved.
- The company's failure to become current in its public reporting obligations could negatively impact its ability to raise capital.
- The company may have difficulty finding alternative sources of capital if delisted from Nasdaq.
Future Outlook
The company's future depends on regaining compliance with Nasdaq listing standards and securing additional financing. The company is working to become current with SEC reporting and is seeking stockholder approval for key transactions to achieve these goals.
Management Comments
- The Board has determined that approval of the matters to be considered at the Special Meeting is in the best interests of the Company and its stockholders.
- The Board unanimously recommends a vote FOR each matter to be considered.
- We hope you will be able to attend the Special Meeting.
- On behalf of the Board and the officers and employees of the Company, I would like to take this opportunity to thank you for your continued support.
Industry Context
This announcement reflects the challenges faced by companies struggling to maintain compliance with stock exchange listing requirements, particularly in volatile market conditions. The company's actions are similar to those taken by other companies facing delisting threats, including reverse stock splits and strategic financing agreements.
Comparison to Industry Standards
- Reverse stock splits are a common strategy for companies facing delisting due to low share prices, however, they do not guarantee a sustained increase in share price.
- The issuance of large amounts of equity to secure financing is a common practice for companies in financial distress, but it can significantly dilute existing shareholders.
- The company's situation is similar to other companies that have faced Nasdaq delisting notices due to non-compliance with minimum bid price and timely filing requirements, such as those in the biotech and small-cap sectors.
- The company's reliance on a few key investors for financing is a common strategy for companies in financial distress, but it can lead to a loss of control and potential conflicts of interest.
Related Party Transactions
- The company has entered into significant loan and equity transactions with Emblem and PMC, which are considered related parties.
Stakeholder Impact
- Shareholders face potential dilution and the risk of delisting.
- Employees may be affected by the company's financial instability.
- Creditors, particularly Emblem and PMC, have a significant stake in the company's future.
- Customers and suppliers may be impacted by the company's financial challenges.
Next Steps
- Stockholders will vote on the proposals at the special meeting on December 20, 2024.
- The Board of Directors will determine the exact ratio of the reverse stock split if approved.
- The company will file an amended and restated Certificate of Incorporation if the proposals are approved.
- The company will work to regain compliance with Nasdaq listing standards.
- The company will use the proceeds from the transactions to become current with SEC reporting.
Key Dates
| Date | Description |
|---|---|
| September 20, 2024 | Date of the Exchange Agreement with Emblem and PMC. |
| November 18, 2024 | Record date for the special meeting. |
| November 22, 2024 | Approximate date of making the Proxy Statement available to stockholders over the Internet. |
| November 25, 2024 | Approximate date of mailing the Proxy Materials to stockholders. |
| December 20, 2024 | Date of the special meeting of stockholders. |
| March 20, 2025 | Potential maturity date of loans with Emblem and PMC if certain proposals are not approved. |
| April 11, 2025 | Maximum amount of time that can be granted by the Nasdaq Hearings Panel. |
| April 16, 2025 | Potential additional cure period end date for the Nasdaq Minimum Bid Price Rule. |
| April 21, 2025 | Potential additional cure period end date for the Nasdaq Minimum MVPHS Rule. |
| September 20, 2025 | Earliest date that Class C Units can be exchanged for Class A Common Stock unless the share price reaches $12.00. |
Keywords
reverse stock split, Nasdaq listing, equity issuance, Class B Common Stock, Class C units, Emblem Investments, PMC Financial, delisting, SEC reporting, loan agreement, warrants
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.